Author | Brian I. Rini, MD | OncLive

Author | Brian I. Rini, MD

Articles

Tivozanib's Safety Profile Linked With Advantage in Advanced RCC Treatment

May 20, 2020

Article

Brian I. Rini, MD, speaks about the TIVO-3 trial and how its results could provide patients with another “weapon in this disease.”

Dr. Rini on Challenges With Biomarkers in RCC

September 24, 2019

Video

Brian I. Rini, MD, professor of medicine, Cleveland Clinic, discusses challenges with biomarkers in renal cell carcinoma (RCC).

Dr. Rini on Managing the Toxicity of Pembrolizumab Plus Axitinib in mRCC

May 23, 2019

Video

Brian I. Rini, MD, professor of medicine, Cleveland Clinic, discusses managing the toxicity of pembrolizumab plus axitinib in patients with metastatic renal cell carcinoma.

Dr. Rini Discusses Pembrolizumab Plus Axitinib in mRCC

April 24, 2019

Video

Brian I. Rini, MD, professor of medicine, Cleveland Clinic, discusses the combination of pembrolizumab plus axitinib in the treatment of patients with metastatic renal cell carcinoma.

x